ICER releases draft CF report, invites comment
The US Institute for Clinical and Economic Review (ICER) has released its draft evidence report on therapies for cystic fibrosis … read more »
US HHS State of the Department reveals drug pricing plans
Alex Azar, Secretary of the Department of Health and Human Services (HHS), gave some insight into the plans of the … read more »
US embassy to Netherlands comments on compounding proposal
The United States embassy in the Netherlands has released a statement on the Dutch Government plans to allow further forms … read more »
ICER launches framework for Value Assessment
The influential Institute for Clinical and Economic Review (ICER) has completed its work to define a new Value Assessment Framework, … read more »
Price rises expected in USA
Numerous reports point to raising of drugs prices across the pharmaceutical sector at the start of 2020. Reuters reported as … read more »
250 drugs to be affected by US Democrat’s pricing proposals
Nancy Pelosi, Speaker of the United States House of Representatives, has published Democratic Party pricing proposals for medicines in the … read more »
US lawmakers seek answers on generic medicine pricing from industry
The Chairman of the House Committee on Oversight and Reform, Rep. Elijah Cummings, and Senator Bernie Sanders have written to … read more »
Trump announces plans to reimport medicines from Canada
The Trump administration has announced plans to combat high medicine prices by reimporting medicines from Canada, where prices are significantly … read more »
Record settlement with US pharma companies for pay-for-delay agreements
The Californian Attorney General has reached settlement agreements with four pharmaceutical companies in respect of their alleged pay-for-delay practices aimed … read more »
Biosimilar uptake in the US lags behind the EU
A new report suggests relatively low uptake of biosimilars in the US could be costing healthcare providers billions in lost … read more »
